Topics

Time to Tailor NSCLC RT to Spare the Immune System?

12:30 EDT 9 Jul 2019 | MedPageToday

(MedPage Today) -- Doses above 7.3 Gy linked with immune toxicity, shorter survival in stage III patients

Original Article: Time to Tailor NSCLC RT to Spare the Immune System?

NEXT ARTICLE

More From BioPortfolio on "Time to Tailor NSCLC RT to Spare the Immune System?"

Quick Search